CHASITIE MCINTOSH: Open Payments
NPI 1841812591 · AUGUSTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$686 in 33 payments from 9 companies in 2025. Trend: 2023 $357 · 2024 $1,550 · 2025 $686
Food & beverage: $686
| Company | Payments | Amount |
|---|---|---|
| LivaNova USA, Inc. | 14 | $307 |
| UCB, Inc. | 7 | $147 |
| Averitas Pharma Inc. | 2 | $49 |
| Tanabe Pharma America, Inc. | 2 | $44 |
| Alexion Pharmaceuticals, Inc. | 2 | $38 |
| Teva Pharmaceuticals USA, Inc. | 2 | $31 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $29 |
| ARGENX US, INC. | 1 | $23 |
| Merz Pharmaceuticals, LLC | 1 | $17 |
Products named: VNS THERAPY SENTIVA MODEL 1000 GENERATOR, Zilbrysq, QUTENZA, Radicava, Rystiggo, ULTOMIRIS, Nayzilam, AUSTEDO XR.
Industry payments across GA — which companies pay providers there.
